Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi survey: Expert Opinion on Pharmacotherapy

M. Falconi, N. Fazio, D. Ferone, A. Versari

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi survey: Expert Opinion on Pharmacotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences